-
Afatinib (BIBW 2992) in Assembloid Cancer Models: Workflow &
2026-05-07
Harness the irreversible ErbB family inhibitor Afatinib (BIBW 2992) to dissect EGFR, HER2, and HER4 signaling in patient-derived cancer assembloid systems. This guide outlines optimized protocols, advanced troubleshooting, and actionable insights for studying tumor–stroma interactions and overcoming drug resistance in translational oncology.
-
WP1066: Advanced JAK2/STAT3 Inhibition for Cancer and Beyond
2026-05-07
Discover how WP1066, a potent JAK2/STAT3 inhibitor, is transforming cancer and regenerative research. This article explores mechanisms, protocol insights, and assay planning based on the latest evidence.
-
CDK4’s Role in 4E-BP1 Phosphorylation and Cap-Dependent Tran
2026-05-06
This study identifies cyclin-dependent kinase 4 (CDK4) as a novel regulator of 4E-BP1, demonstrating that CDK4 phosphorylates 4E-BP1 at canonical and noncanonical sites to drive cap-dependent translation during the mitosis–G1 transition. These findings expand the landscape of kinase-mediated translational control and suggest new avenues for cancer and cell cycle research.
-
EZ Cap Cy5 Firefly Luciferase mRNA: Quantitative Tracking &
2026-05-06
Unlock quantitative mRNA delivery tracking and translation efficiency analysis with EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP). This article uniquely connects dual-modality mRNA reporters to nanoparticle manufacturing innovations, guiding advanced assay design and interpretation.
-
Paclitaxel (Taxol): Mechanistic Benchmarks in Cancer Researc
2026-05-05
Paclitaxel (Taxol) is a highly potent microtubule stabilizer, essential for dissecting cell cycle arrest and apoptosis in cancer research. Its efficacy in ovarian and breast cancer models is benchmarked by precise, low-nanomolar IC50 values and validated angiogenesis inhibition. APExBIO’s Paclitaxel (A4393) is a rigorously characterized tool compound for translational studies.
-
2-APB: Precision Tool for Calcium Oscillation and Apoptosis
2026-05-05
2-APB (2-aminoethoxydiphenyl borate) uniquely enables researchers to dissect ER-mediated calcium signaling, autophagy, and apoptosis transitions, as elegantly demonstrated in Bombyx mori starvation models. This article delivers actionable protocol guidance, troubleshooting strategies, and workflow enhancements grounded in the latest evidence and APExBIO's proven reagent quality.
-
Alosetron: 5-HT3 Receptor Antagonist in Gut Polarity Researc
2026-05-04
Alosetron empowers researchers to probe gastrointestinal motility and epithelial polarity by selectively targeting 5-HT3 receptor signaling. This guide details protocol optimization, advanced applications, and troubleshooting strategies for reproducible results in intestinal stem cell and gut homeostasis studies.
-
BMS 599626 Dihydrochloride: Reliable EGFR/ErbB2 Inhibition f
2026-05-04
This article offers practical, scenario-driven guidance for researchers using BMS 599626 dihydrochloride (SKU B5792) in cell viability and proliferation assays. Learn how this selective EGFR and ErbB2 inhibitor ensures reproducibility, sensitivity, and consistency in cancer biology and senescence research workflows.
-
17-AAG (Tanespimycin): Applied HSP90 Inhibition in Oncology
2026-05-03
17-AAG (Tanespimycin) empowers translational cancer research with reproducible, potent HSP90 inhibition and apoptosis induction across diverse tumor models. This guide delivers actionable workflows, advanced troubleshooting, and the latest insights bridging chaperone biology and cell death mechanisms.
-
Quantifying Pulmonary Arterial Remodeling’s Impact on RV Loa
2026-05-02
This study employs a subject-specific, 1D fluid–structure interaction model to dissect the distinct contributions of pulmonary arterial remodeling—namely increased distal resistance and decreased vessel compliance—to elevated right ventricular afterload in pulmonary hypertension. The findings enhance mechanistic understanding of hemodynamic progression in PH, enabling researchers to target interventions more precisely.
-
ISRIB (trans-isomer): Redefining ATF4-Directed Fibrosis Assa
2026-05-02
Explore how ISRIB (trans-isomer) advances ER stress research by enabling precise, ATF4-focused modulation in fibrosis and apoptosis assays. This article uniquely connects recent hepatic fibrosis findings to optimized ISRIB use in translational models.
-
Tetracycline as a Broad-Spectrum Polyketide Antibiotic in Mo
2026-05-01
Tetracycline’s unique mechanism as a broad-spectrum polyketide antibiotic extends far beyond routine selection, enabling precision studies in ribosomal function and bacterial membrane integrity. Explore protocol enhancements, troubleshooting strategies, and advanced applications informed by the latest experimental breakthroughs.
-
Firefly Luciferase mRNA (5-moUTP): Workflow Optimization & U
2026-04-30
EZ Cap™ Firefly Luciferase mRNA (5-moUTP) empowers labs to achieve robust, immune-evasive bioluminescent reporting with enhanced translation and stability. This guide demystifies applied workflows and troubleshooting, leveraging cutting-edge research for reproducible results.
-
Bradykinin (BA5201): Protocols for Vascular and Inflammation
2026-04-30
Bradykinin (SKU BA5201) is a well-characterized endothelium-dependent vasodilator peptide supplied by APExBIO, designed for controlled studies in vascular permeability and inflammation pathways. This product offers reproducible results in assays targeting smooth muscle contraction, pain mechanisms, and cardiovascular physiology. It is not recommended for diagnostic or long-term clinical applications due to stability and intended-use limitations.
-
Prostaglandin E2 in Translational Cardiovascular and Mucosal
2026-04-29
Explore the multi-dimensional impact of Prostaglandin E2 (PGE2) in translational research, with a spotlight on cardiovascular and gastrointestinal mucosal protection. This article delivers a unique, mechanism-driven perspective informed by cutting-edge network pharmacology.
406 records 16/28 page Previous Next First page 上5页 1617181920 下5页 Last page